Heart Failure and Shared Decision-Making: Patients Open to Medication-Related Cost Discussions

Circ Heart Fail. 2020 Nov;13(11):e007094. doi: 10.1161/CIRCHEARTFAILURE.120.007094. Epub 2020 Nov 12.

Abstract

Background: Discussions of medication costs between patients and clinicians are infrequent and often suboptimal. In the context of recently introduced drugs that are effective but expensive, patients with heart failure with reduced ejection fraction provide an ideal population to understand the perspectives of patients with chronic illness on medication cost and cost discussions.

Methods: To explore patients' perspectives on discussing out-of-pocket medication costs with clinicians, 49 adults, aged 44 to 70 years, with heart failure with reduced ejection fraction were recruited from outpatient heart failure clinics. Descriptive qualitative analysis was performed on open-ended text data.

Results: Participants who had prior medication-related cost discussions described their experience as generally positive, but about half of the participants had never had a cost discussion with their clinician. Most participants were open to cost discussions with clinicians and preferred that the clinician initiate discussions regarding medication cost. Importantly, these preferences held constant across reported levels of financial burden.

Conclusions: These data suggest a substantial willingness on the part of patients with heart failure with reduced ejection fraction to incorporate cost discussions into their care and identify important aspects of these discussions for clinicians to consider when engaging in conversations where cost is relevant. Improving understanding about how to integrate patient preferences regarding cost discussions into clinical encounters is an important priority for advancing patient-centered care.

Keywords: decision-making; heart failure; outpatients; patient preferences; patient-centered care.

MeSH terms

  • Adult
  • Aged
  • Aminobutyrates / economics*
  • Aminobutyrates / therapeutic use
  • Attitude of Health Personnel
  • Biphenyl Compounds
  • Cardiovascular Agents / economics*
  • Cardiovascular Agents / therapeutic use
  • Choice Behavior
  • Decision Making, Shared*
  • Drug Combinations
  • Drug Costs*
  • Female
  • Health Expenditures*
  • Health Knowledge, Attitudes, Practice
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy
  • Heart Failure / economics*
  • Heart Failure / physiopathology
  • Humans
  • Interviews as Topic
  • Male
  • Middle Aged
  • Patient Participation*
  • Patient Preference
  • Patient-Centered Care
  • Physician-Patient Relations*
  • Tetrazoles / economics*
  • Tetrazoles / therapeutic use
  • Valsartan

Substances

  • Aminobutyrates
  • Biphenyl Compounds
  • Cardiovascular Agents
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • sacubitril and valsartan sodium hydrate drug combination